Edition:
India

XBiotech Inc (XBIT.OQ)

XBIT.OQ on NASDAQ Stock Exchange Global Select Market

4.78USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$4.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,046
52-wk High
$17.98
52-wk Low
$2.80

Latest Key Developments (Source: Significant Developments)

XBiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology
Monday, 16 Apr 2018 

April 16 (Reuters) - XBiotech Inc ::XBIOTECH ANNOUNCES UPCOMING PHASE 2 CLINICAL STUDIES IN DERMATOLOGY.XBIOTECH INC - CO WOULD EVALUATE A NEW SUBCUTANEOUS FORMULATION OF CO'S TRUE HUMAN MONOCLONAL ANTIBODY, MABP1, IN TWO SEPARATE PHASE 2 STUDIES.XBIOTECH INC - UPCOMING PHASE 2 CLINICAL STUDIES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (AD) AND HIDRADENITIS SUPPURATIVA (HS).  Full Article

XBiotech says announces successful completion of EMA GMP inspection
Wednesday, 12 Oct 2016 

XBiotech Inc : XBiotech announces successful completion of EMA GMP inspection . Says findings allow french agency to recommend to EMA xBiotech's current facility for commercial manufacture of xilonix .XBiotech inc - company expects EMA decision on marketing application as early as end of 2016.  Full Article

Xbiotech files for stock shelf of upto 7 mln shares
Saturday, 20 Aug 2016 

Xbiotech Inc :Files for stock shelf of up to 7 million common shares - SEC filing.  Full Article

XBiotech signs agreement with Megapharm to market xilonix in israel
Tuesday, 28 Jun 2016 

XBiotech Inc : XBiotech signs agreement with Megapharm to market xilonix in Israel . XBiotech Inc says under terms of agreement, Megapharm will pay XBiotech an undisclosed upfront fee .In addition, upon approval, Megapharm will purchase xilonix from XBiotech at a supply price that is based on a percentage of net sales of product.  Full Article

XBiotech Inc appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer
Tuesday, 3 May 2016 

XBiotech Inc:Says appointment of Scott Whitehurst as Chief Financial Officer.  Full Article